Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

PBD Biotech recognised at Norfolk Business Awards

Local start-up PBD Biotech was announced as finalists for the Norfolk Business Awards’ “Breaking Boundaries” category and “Knowledge Pioneer of 2018” at a black-tie ceremony held at Norfolk Showground this week (22 November).
  • November 23, 2018
  • Company
  • award, innovation
PBD Biotech at the Norfolk Business Awards

The Knowledge Pioneer Award, one of 11 awards coordinated by the Eastern Daily Press, specifically recognises ambitious businesses with a commitment to acquiring and instilling knowledge in their organisation in order to achieve their strategic goals.

The Breaking Boundaries category celebrates transformational companies and individuals who embrace growth opportunities.

At the awards ceremony, hosted by comedian Katherine Ryan, Dr Berwyn Clarke, co-founder and CEO of PBD Biotech, commented, “We established PBD Biotech less than two years ago, so to be recognised as breaking boundaries and knowledge pioneers – alongside established international companies – is a real testament to how far we’ve already come.

“Congratulations to FXHome and Chadwicks, respectively.”

The Norfolk Business Awards highlight the people and companies who are achieving and excelling in East Anglia – setting an example to others and representing the region on a national and international stage.

Since 2016, PBD Biotech has gained UK Government approval for exceptional private use of their Actiphage® diagnostic; proven efficacy in the field; opened an office in Canada; and started international trials.

Next week, Dr Clarke will be in India, as part of the UK Government Department of International Trade delegation, discussing the advantages of the company’s Actiphage test with farmers, dairy producers and healthcare providers.

Share:

Related posts

Loading...
SREDA logo

PBD Biotech wins competition to present to Canadian agricultural industry

June 30, 2017
PBD Biotech Ltd has won a competition organized by the Saskatoon Regional Economic Development Authority (SREDA) as part of their HARVEST Program. This program is designed to bring selected international companies to Western Canada’s Outdoor Farm Expo to present their...
SREDA logo

PBD Biotech wins competition to present to Canadian agricultural industry

June 30, 2017
PBD Biotech Ltd has won a competition organized by the Saskatoon Regional Economic Development Authority (SREDA) as part of their...

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More